Clover Health Appoints New CMO, Board Member
Ticker: CLOV · Form: 8-K · Filed: Aug 22, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Aug 22, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $200,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-of-directors, personnel
Related Tickers: CLOV
TL;DR
Clover Health brings in Dr. Gollaher as new CMO & board member, Dr. Wilson departs.
AI Summary
Clover Health Investments Corp. announced on August 20, 2024, changes in its executive team and board of directors. Specifically, the company appointed Dr. David M. Gollaher as Chief Medical Officer and elected him to the Board of Directors. Additionally, the company announced the departure of Dr. Andrew M. Wilson from his role as Chief Medical Officer and his resignation from the Board of Directors, effective August 16, 2024.
Why It Matters
This leadership change in a key medical role could signal a shift in the company's strategic direction or focus on specific healthcare initiatives.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Clover Health Investments Corp. (company) — Registrant
- Dr. David M. Gollaher (person) — Appointed Chief Medical Officer and elected to the Board of Directors
- Dr. Andrew M. Wilson (person) — Departed Chief Medical Officer and resigned from the Board of Directors
- August 20, 2024 (date) — Date of earliest event reported
- August 16, 2024 (date) — Effective date of Dr. Wilson's departure
FAQ
Who has been appointed as the new Chief Medical Officer for Clover Health?
Dr. David M. Gollaher has been appointed as the new Chief Medical Officer for Clover Health.
When did Dr. Andrew M. Wilson's departure become effective?
Dr. Andrew M. Wilson's departure from his role as Chief Medical Officer and resignation from the Board of Directors were effective August 16, 2024.
What other role has Dr. David M. Gollaher taken on?
In addition to being appointed Chief Medical Officer, Dr. David M. Gollaher has also been elected to the Board of Directors of Clover Health.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is August 20, 2024.
What are the key items reported in this 8-K filing?
This 8-K filing reports on the departure of certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.
Filing Stats: 877 words · 4 min read · ~3 pages · Grade level 10.3 · Accepted 2024-08-22 09:02:05
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
- $200,000 — s A Common Stock having an RSU value of $200,000, pro-rated by multiplying such amount b
Filing Documents
- clov-20240820.htm (8-K) — 30KB
- exhibit991-directorappoint.htm (EX-99.1) — 7KB
- 0001801170-24-000182.txt ( ) — 165KB
- clov-20240820.xsd (EX-101.SCH) — 2KB
- clov-20240820_lab.xml (EX-101.LAB) — 22KB
- clov-20240820_pre.xml (EX-101.PRE) — 13KB
- clov-20240820_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press release dated A ugust 22 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: August 22, 2024 By: /s/ Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary